Comparison of Microbiological Profiles of Primary Hip and Knee Peri-Prosthetic Joint Infections Treated at Specialist Centers Around the World
- PMID: 40732014
- PMCID: PMC12299316
- DOI: 10.3390/microorganisms13071505
Comparison of Microbiological Profiles of Primary Hip and Knee Peri-Prosthetic Joint Infections Treated at Specialist Centers Around the World
Abstract
Periprosthetic joint infection (PJI) is a complex complication of total joint arthroplasty, with microbiological profiles varying across centers worldwide. However, most studies are limited to single-center or intra-country multicenter analyses, often including mixed cohorts of primary and revision PJI cases, with limited data regarding global antibiotic resistance patterns. This study compared the microbiological characteristics, polymicrobial culture rates, prevalence of culture-negative infections, and antibiotic resistance patterns in PJI cases across five referral centers from five continents. A total of 717 patients with primary hip and knee PJI were included from centers in Argentina, Canada, Turkey, England, and New Zealand. Staphylococcus aureus and Staphylococcus epidermidis were the most common pathogens (48.5%, p < 0.01). Culture-negative infection rates varied significantly, ranging from 4.2% (England) to 24.6% (Turkey) (p < 0.01). Polymicrobial infections were the most frequent in Canada (8.9%) and the least frequent in England (1.1%) (p < 0.01). Gram-negative bacteria comprised 13.1% of culture-positive cases, with no significant intercountry difference. Multidrug resistance was observed in all centers, ranging from 23.7% (Argentina) to 43.1% (Turkey), with no statistical significance. Vancomycin resistance was detected in England (2.3%) and Canada (1.2%) but absent in Turkey, New Zealand, and Argentina. These findings underscore significant intercontinental variability, emphasizing the need for regional considerations in regards to empiric antibiotic selection and PJI management.
Keywords: PJI; antibiotic resistance; culture; microbiological profile; microbiological trends; periprosthetic joint infection.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Organism profiles and empirical treatments for periprosthetic joint infections.J Orthop Surg Res. 2025 Jul 25;20(1):698. doi: 10.1186/s13018-025-06007-4. J Orthop Surg Res. 2025. PMID: 40713651 Free PMC article.
-
How Often Does Bacteremia Occur in Patients With Chronic Periprosthetic Joint Infection? A Prospective, Observational Study.Clin Orthop Relat Res. 2025 Jan 21;483(7):1206-1214. doi: 10.1097/CORR.0000000000003367. Clin Orthop Relat Res. 2025. PMID: 39843348
-
Does Cement Viscosity Impact Antibiotic Elution and In Vitro Efficacy Against Common Prosthetic Joint Infection Pathogens?Clin Orthop Relat Res. 2025 Mar 1;483(3):488-497. doi: 10.1097/CORR.0000000000003272. Epub 2024 Oct 2. Clin Orthop Relat Res. 2025. PMID: 39724555
-
Bacteriophage therapy as an innovative strategy for the treatment of Periprosthetic Joint Infection: a systematic review.Int Orthop. 2024 Nov;48(11):2809-2825. doi: 10.1007/s00264-024-06295-1. Epub 2024 Sep 10. Int Orthop. 2024. PMID: 39254722 Free PMC article.
-
Safety and effectiveness of intraosseous regional prophylactic antibiotics in total knee arthroplasty: a systematic review and meta-analysis.Arch Orthop Trauma Surg. 2024 Sep;144(9):4233-4245. doi: 10.1007/s00402-024-05513-0. Epub 2024 Sep 19. Arch Orthop Trauma Surg. 2024. PMID: 39297962
References
-
- Weinstein E.J., Stephens-Shields A.J., Newcomb C.W., Silibovsky R., Nelson C.L., O’Donnell J.A., Glaser L.J., Hsieh E., Hanberg J.S., Tate J.P., et al. Incidence, Microbiological Studies, and Factors Associated With Prosthetic Joint Infection After Total Knee Arthroplasty. JAMA Netw. Open. 2023;6:e2340457. doi: 10.1001/jamanetworkopen.2023.40457. - DOI - PMC - PubMed
-
- Jin X., Gallego Luxan B., Hanly M., Pratt N.L., Harris I., de Steiger R., Graves S.E., Jorm L. Estimating incidence rates of periprosthetic joint infection after hip and knee arthroplasty for osteoarthritis using linked registry and administrative health data. Bone Joint J. 2022;104-B:1060–1066. doi: 10.1302/0301-620X.104B9.BJJ-2022-0116.R1. - DOI - PMC - PubMed
-
- Kurtz S.M., Lau E.C., Son M.S., Chang E.T., Zimmerli W., Parvizi J. Are We Winning or Losing the Battle With Periprosthetic Joint Infection: Trends in Periprosthetic Joint Infection and Mortality Risk for the Medicare Population. J. Arthroplast. 2018;33:3238. doi: 10.1016/j.arth.2018.05.042. - DOI - PubMed
LinkOut - more resources
Full Text Sources